Additionally, Kaplan–Meier survival analysis of a cohort of 2166 patients demonstrated that high VEGFA levels were significantly associated with poorer prognosis in NSCLC patients compared to lower VEGFA levels (Figure 1j). The gene discussed is VEGFA; the disease is non-small cell lung carcinoma.